Bone Tissue Engineering Using High Permeability Poly-Ε-Caprolactone Scaffolds Conjugated With Bone Morphogenetic Protein-2

Links

URL: http://hdl.handle.net/2027.42/95994

OCLC: 1194605599

ADS: 2012PhDT.......324M

Abstract

Bone is the second most commonly transplanted tissue in the United States. Limitations of current bone defect treatment options include morbidity at the autograft harvest site, mechanical failure, and poorly controlled growth factor delivery. Combining synthetic scaffolds with biologies may address these issues and reduce dependency on autografts. The ideal scaffolding system should promote tissue in-growth and nutrient diffusion, control delivery of biologies and maintain mechanical integrity during bone formation. This dissertation evaluates how scaffold permeability, conjugated bone morphogenetic protein-2 (BMP-2) and differentiation medium affect osteogenesis in vitro and bone growth in vivo.

"High" and "low" permeability polycaprolactone (PCL) scaffolds with regular architectures were manufactured using solid free form fabrication. Bone growth in vivo was evaluated in an ectopic mouse model. High permeability scaffolds promoted better 8 week bone growth, supported tissue penetration into the scaffold core, and demonstrated increased mechanical properties due to newly formed bone. Next, the effects of differentiation medium and conjugated BMP-2 on osteogenesis were compared. Conjugation may improve BMP-2 loading efficiency, help localize bone growth and control release. High permeability scaffolds were conjugated with BMP-2 using the crosslinker, sulfo-SMCC. When adipose-derived and bone marrow stromal cells were seeded onto constructs (with or without BMP-2), BMSC expressed more differentiation markers, and differentiation medium affected differentiation more than BMP-2. In vivo, scaffolds with ADSC pre-differentiated in osteogenic medium (with and without BMP-2) and scaffolds with only BMP-2 grew the most bone. Bone volume did not differ among these groups, but constructs with ADSC had evenly distributed, scaffold-guided bone growth.

Analysis of two additional BMP-2 attachment methods (heparin and adsorption) showed highest conjugation efficiency for the sulfo-SMCC method. BMP-2 release from all constructs was minimal, proving that BMP-2 was tightly bound to constructs regardless of the attachment method. However, C2C12 myoblasts did not produce alkaline phosphatase when seeded onto heparin- and sulfo-SMCC-conjugated scaffolds suggesting hindrance of BMP-2 bioactivity.

This thesis demonstrated that high permeability PCL scaffolds promote bone growth better than low permeability scaffolds and that in vitro pre-differentiation of cells affects osteogenesis more than conjugated BMP-2. Future work will optimize BMP-2 conjugation to ensure maintenance of bioactivity.

Cited Works (17)

Year	Entry
1993	Fung YC. Biomechanics: Mechanical Properties of Living Tissues. 2nd ed. New York, NY: Springer-Verlag; 1993.
1997	Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsent G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell. May 30, 1997;89(5):747-754.
2005	Sakaguchi Y, Sekiya I, Yagishita K, Muneta T. Comparison of human stem cells derived from various mesenchymal tissues: superiority of synovium as a cell source. Arthritis Rheum. August 2005;52(8):2521-2529.
2005	Williams JM, Adewunmi A, Schek RM, Flanagan CL, Krebsbach PH, Feinberg SE, Hollister SJ, Das S. Bone tissue engineering using polycaprolactone scaffolds fabricated via selective laser sintering. Biomaterials. August 2005;26(23):4817-4827.
2002	Zein I, Hutmacher DW, Tan KC, Teoh SH. Fused deposition modeling of novel scaffold architectures for tissue engineering applications. Biomaterials. February 15, 2002;23(4):1169-1185.
1983	Urist MR, DeLange RJ, Finerman GA. Bone cell differentiation and growth factors. Science. May 13, 1983;220(4598):680-686.
2010	Kang HS. Hierarchical Design and Simulation of Tissue Engineering Scaffold Mechanical, Mass Transport, and Degradation Properties [PhD thesis]. University of Michigan; 2010.
2002	Roeder BA, Kokini K, Sturgis JE, Robinson JP, Voytik-Harbin SL. Tensile mechanical properties of three-dimensional type I collagen extracellular matrices with varied microstructure. J Biomech Eng. April 2002;124(2):214-222.
2005	Karageorgiou V, Kaplan D. Porosity of 3D biomaterial scaffolds and osteogenesis. Biomaterials. September 2005;26(27):5474-5491.
1988	Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM, Wang EA. Novel regulators of bone formation: molecular clones and activities. Science. December 16, 1988;242(4885):1528-1534.
1997	Misof K, Landis WJ, Klaushofer K, Fratzl P. Collagen from the osteogenesis imperfecta mouse model (oim) shows reduced resistance against tensile stress. J Clin Invest. July 1997;100(1):40-45.
2008	Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C_T method. Nat Protoc. 2008;3(6):1101-1108.
2008	Shapiro F. Bone development and its relation to fracture repair: the role of mesenchymal osteoblasts and surface osteoblasts. Eur Cell Mater. 2008;15:53-76.
1999	Gerber H-P, Vu TH, Ryan AM, Kowalski J, Werb Z, Ferrara N. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med. June 1999;5(6):623-628.
1965	Urist MR. Bone: formation by autoinduction. Science. November 12, 1965;150(3698):893-899.
1992	Yasko AW, Lane JM, Fellinger EJ, Wozney JM, Wang EA. The healing of segmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2): a radiographic, histological, and biomechanical study in rats. J Bone Joint Surg. June 1992;74A(5):659-670.
2001	Hutmacher DW, Schantz T, Zein I, Ng KW, Teoh SH, Tan KC. Mechanical properties and cell cultural response of polycaprolactone scaffolds designed and fabricated via fused deposition modeling. J Biomed Mater Res. May 2001;55(2):203-216.